12.09
Vicarious Surgical Inc stock is traded at $12.09, with a volume of 48,666.
It is down -1.07% in the last 24 hours and down -3.37% over the past month.
Vicarious Surgical Inc designs a surgical robot that enables surgeons to perform minimally invasive surgery with 3D visualization and accurate control. Its Vicarious Surgical Robotic System is designed with a focus on abdominal access and visualization through a single port.
See More
Previous Close:
$12.17
Open:
$12.16
24h Volume:
48,666
Relative Volume:
1.06
Market Cap:
$72.20M
Revenue:
-
Net Income/Loss:
$-71.07M
P/E Ratio:
-24.67
EPS:
-0.49
Net Cash Flow:
$-63.98M
1W Performance:
-8.65%
1M Performance:
-3.37%
6M Performance:
+118.91%
1Y Performance:
+0.33%
Vicarious Surgical Inc Stock (RBOT) Company Profile
Name
Vicarious Surgical Inc
Sector
Industry
Phone
(617) 868-1700
Address
78 FOURTH AVENUE, WALTHAM
Compare RBOT with other stocks
Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
---|---|---|---|---|---|---|
![]()
RBOT
Vicarious Surgical Inc
|
12.00 | 72.20M | 0 | -71.07M | -63.98M | -0.49 |
![]()
ABT
Abbott Laboratories
|
130.35 | 226.60B | 41.95B | 13.40B | 6.49B | 7.65 |
![]()
BSX
Boston Scientific Corp
|
105.41 | 156.34B | 16.75B | 1.85B | 1.89B | 1.25 |
![]()
SYK
Stryker Corp
|
384.84 | 148.06B | 22.60B | 2.99B | 3.49B | 7.76 |
![]()
MDT
Medtronic Plc
|
91.28 | 117.13B | 33.00B | 4.29B | 5.50B | 3.27 |
![]()
EW
Edwards Lifesciences Corp
|
75.31 | 44.21B | 6.60B | 4.16B | 490.10M | 6.93 |
Vicarious Surgical Inc Stock (RBOT) Upgrades & Downgrades
Date | Action | Analyst | Rating Change |
---|---|---|---|
Mar-04-22 | Downgrade | Piper Sandler | Overweight → Neutral |
Jan-07-22 | Initiated | Credit Suisse | Outperform |
Dec-07-21 | Initiated | Cowen | Outperform |
Nov-05-21 | Initiated | Canaccord Genuity | Buy |
Oct-18-21 | Initiated | BTIG Research | Buy |
Oct-07-21 | Initiated | Piper Sandler | Overweight |
View All
Vicarious Surgical Inc Stock (RBOT) Latest News
(RBOT) Long Term Investment Analysis - Stock Traders Daily
(RBOT) Proactive Strategies - Stock Traders Daily
Encision Signs Master Services Agreement with Vicarious Surgical Inc. - ACCESS Newswire
Vicarious Surgical enters consulting agreement with former CFO By Investing.com - Investing.com South Africa
Vicarious Surgical enters consulting agreement with former CFO - MSN
Vicarious Surgical Inc. Enters into Consulting Agreement with Former CFOWASHINGTON, D.C. 20549 — On January 17, 2025, Vicarious Surgical Inc. (NYSE: RBOT) filed a current report on Form 8-K with the Securities and Exchange Commission, detailing th - Defense World
Vicarious Surgical Secures Advisory Role with Former CFO - TipRanks
Vicarious Surgical (NYSE:RBOT) & Coloplast A/S (OTCMKTS:CLPBY) Head to Head Review - Defense World
How the (RBOT) price action is used to our Advantage - Stock Traders Daily
Vicarious Surgical (NYSE:RBOT) Trading Up 9.7%What's Next? - MarketBeat
Objective long/short (RBOT) Report - Stock Traders Daily
How does Vicarious Surgical plan to Revolutionize Robotic Surgery🍩 Conheça a SV Bet! - Oficjalny Portal Gminy Brzesko
Vicarious Surgical CEO Discusses Novel Approach to Surgical Robotics🥎 Conheça a Real Pilar! - Oficjalny Portal Gminy Brzesko
Vicarious Surgical Inc (NYSE:RBOT) Sees Large Growth in Short Interest - MarketBeat
Vicarious Surgical CFO William Kelly stepping down in January - MedTech Dive
Vicarious Surgical’s CFO William Kelly to Depart in 2025 - MPO-mag
Vicarious Surgical CFO moves on - Medical Buyer
Vicarious Surgical CFO William Kelly to Depart - citybiz
Vicarious Surgical Announces CFO William Kelly’s Resignation - TipRanks
Vicarious Surgical CFO to Step Down - MarketWatch
Vicarious Surgical Announces Departure of Chief Financial Officer - The Bakersfield Californian
Vicarious Surgical Inc. Announces Departure of William Kelly as Chief Financial Officer, Effective January 2, 2025 - Marketscreener.com
Vicarious Surgical (NYSE:RBOT) Trading Down 9%Here's Why - MarketBeat
Vicarious surgical CTO Khalifa Sammy sells stock for $3,216 By Investing.com - Investing.com Australia
Vicarious Surgical COO Mazzola sells $3,047 in stock By Investing.com - Investing.com Australia
Vicarious Surgical CEO sells $6,251 in stock to cover tax obligations - Investing.com Nigeria
Vicarious Surgical CFO sells $2,923 in stock By Investing.com - Investing.com Canada
Vicarious surgical CTO Khalifa Sammy sells stock for $3,216 - Investing.com
We're Keeping An Eye On Vicarious Surgical's (NYSE:RBOT) Cash Burn Rate - Simply Wall St
Vicarious Surgical CFO sells shares worth $976 - Investing.com India
Vicarious Surgical CEO Adam Sachs sells $7,327 in stock to cover taxes - Investing.com Nigeria
Vicarious surgical CTO Khalifa Sammy sells shares worth $5,855 By Investing.com - Investing.com Australia
Vicarious surgical CTO Khalifa Sammy sells shares worth $5,855 - Investing.com
Vicarious Surgical CFO sells shares worth $976 By Investing.com - Investing.com UK
Here's Why Vicarious Surgical (NYSE:RBOT) Must Use Its Cash Wisely - Yahoo Finance
How To Trade (RBOT) - Stock Traders Daily
Vicarious Surgical says first surgical robot trials remain on track, analysts remain neutral - Mass Device
Earnings call: Vicarious Surgical reports narrowed Q3 loss, progress on tech - Investing.com
Vicarious Surgical stock target cut, keeps neutral rating on Q3 loss - Investing.com
Vicarious Surgical price target lowered to $10.50 from $12 at Piper Sandler - TipRanks
Vicarious Surgical Inc. (NYSE:RBOT) Q3 2024 Earnings Call Transcript - Insider Monkey
Vicarious Surgical operating expenses decrease 17% in Q3 2024 - Medical Buyer
Vicarious Surgical Inc. Reports Q3 2024 Financial Results - TipRanks
Vicarious Surgical (RBOT) to Release Quarterly Earnings on Tuesday - Defense World
Vicarious Surgical to Report Third Quarter 2024 Financial Results on November 12, 2024 - StockTitan
Vicarious Surgical Inc (RBOT) Q2 2024 Earnings Call Highlights: Strategic Partnerships and ... By GuruFocus - Investing.com Canada
Vicarious Surgical Inc Stock (RBOT) Financials Data
Revenue
Net Income
Cash Flow
EPS
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):